Talk on AI and Precision Medicine from Founder and Director of Scripps Research Translational Institute

May 19, 2021 3:00 p.m. - 4:00 p.m. ET

Deep learning, a subtype of artificial intelligence (AI), has considerable transformative potential to promote accuracy, streamline workflow, synthesize data for both clinicians and patients, promote patient autonomy, and greatly enhance the patient-clinician relationship. To date, however, prospective validation studies are quite limited.

Dr. Eric Topol, M.D., will discuss how we need to confront such vital issues of how AI can unintentionally worsen inequities and discrimination. The goal, which may be considered counter-intuitive, is to use this technology to make medicine more human.

Dr. Eric Topol, M.D.

Eric Topol, M.D., founder and director of the Scripps Research Translational Institute, is widely known for his development of genomic and digital tools coupled with AI analytics geared to individualize medicine.

Vote below about this page’s helpfulness.

Enter the characters shown in the image.